J. Dannull
Overview
Explore the profile of J. Dannull including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dannull J, Cerny T, Ackermann D, Groettrup M
Onkologie
. 2001 Jul;
23(6):544-551.
PMID: 11441259
For several decades, approaches utilizing nonspecific immune stimulants have provided evidence that the immune system, when properly activated, may eradicate cancer cells. However, it was only after the identification of...
2.
Dannull J, Diener P, Prikler L, Furstenberger G, Cerny T, Schmid U, et al.
Cancer Res
. 2000 Oct;
60(19):5522-8.
PMID: 11034097
Immunotherapy of prostate cancer (CaP) may be a promising novel treatment option for the management of advanced CaP. However, the lack of suitable tumor antigens remains a major obstacle for...
3.
Mulders P, Tso C, Pang S, Kaboo R, McBride W, Hinkel A, et al.
J Immunother
. 1998 Jun;
21(3):170-80.
PMID: 9610908
Combination therapy with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes (TILs) demonstrates significant clinical activity in patients with metastatic renal cell carcinoma (RCC). To investigate whether local delivery of IL-2 via gene...
4.
Mulders P, Pang S, Dannull J, Kaboo R, Hinkel A, Michel K, et al.
Cancer Res
. 1998 Mar;
58(5):956-61.
PMID: 9500456
Dendritic cells (DCs) are capable of presenting tumor-associated antigens and subsequently play an essential role in T-cell activation. The aim of this study was to develop an efficient method for...
5.
Dannull J, Belldegrun A
Br J Urol
. 1997 Mar;
79 Suppl 1:97-103.
PMID: 9088281
No abstract available.
6.
Pang S, Dannull J, Kaboo R, Xie Y, Tso C, Michel K, et al.
Cancer Res
. 1997 Feb;
57(3):495-9.
PMID: 9012480
The prostate-specific antigen (PSA) promoter (PSA-P) has been identified, characterized, and determined to be tissue specific. Compared with high expression of the genomic PSA gene in prostate cells, expression of...
7.
Schmalzbauer E, Strack B, Dannull J, Guehmann S, Moelling K
J Virol
. 1996 Feb;
70(2):771-7.
PMID: 8551614
The nucleocapsid (NC) protein of human immunodeficiency virus type 1 is required for packaging of viral RNA and for virion assembly. It contains two clusters of basic amino acids, consisting...
8.
Muller G, Strack B, Dannull J, Sproat B, Surovoy A, Jung G, et al.
J Mol Biol
. 1994 Sep;
242(4):422-9.
PMID: 7932701
The nucleocapsid protein NCp7 of HIV-1 is a single-stranded nucleic acid binding protein with several functions such as specific recognition, dimerization and packaging of viral RNA, tRNA annealing to viral...
9.
Moelling K, Mueller G, Dannull J, Reuss C, Beimling P, Bartz C, et al.
Ann N Y Acad Sci
. 1994 Sep;
733:113-21.
PMID: 7978859
No abstract available.
10.
Dannull J, Surovoy A, Jung G, Moelling K
EMBO J
. 1994 Apr;
13(7):1525-33.
PMID: 8156990
The nucleocapsid (NC) protein of human immunodeficiency virus HIV-1 (NCp7) is responsible for packaging the viral RNA by recognizing a packaging site (PSI) on the viral RNA genome. NCp7 is...